Skip to main content
logo
Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
20.57
-0.88 (-4.10%)
At close: Jul 2, 2026, 4:00 PM EDT
21.38
+0.81 (3.94%)
After-hours: Jul 2, 2026, 6:01 PM EDT

Seaport Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Net Income
-74.88-46.88
Depreciation & Amortization
0.170.17
Stock-Based Compensation
6.8814.52
Other Adjustments
-2.190.05
Changes in Accounts Payable
-3.072.07
Changes in Accrued Expenses
3.950.92
Changes in Other Operating Activities
-8.81-0.48
Operating Cash Flow
-77.94-29.63
Capital Expenditures
-0.36-0.11
Purchases of Investments
-396.39-
Proceeds from Sale of Investments
212.5-
Investing Cash Flow
-184.25-0.11
Issuance of Common Stock
0-
Net Common Stock Issued (Repurchased)
0-
Issuance of Preferred Stock
-326.1
Net Preferred Stock Issued (Repurchased)
-326.1
Other Financing Activities
-0.8713.2
Financing Cash Flow
-0.87339.3
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0-
Net Cash Flow
-263.06309.55
SEC Filings: 10-K · 10-Q